HEADER OXIDOREDUCTASE 25-AUG-22 8AUE TITLE 12-OXOPHYTODIENOATE REDUCTASE 3 (OPR3) FROM SOLANUM LYCOPERSICUM IN TITLE 2 COMPLEX WITH 2-METHOXYETHYL (Z)-2-(HYDROXYIMINO)-3-OXOBUTANOATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: 12-OXOPHYTODIENOATE REDUCTASE 3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 12-OXOPHYTODIENOATE-10,11-REDUCTASE 3,OPDA-REDUCTASE 3, COMPND 5 LEOPR3; COMPND 6 EC: 1.3.1.42; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SOLANUM LYCOPERSICUM; SOURCE 3 ORGANISM_COMMON: TOMATO; SOURCE 4 ORGANISM_TAXID: 4081; SOURCE 5 GENE: OPR3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS ENE-REDUCTASE, OXIME, FMN, COMPLEX, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR N.POLIDORI,K.GRUBER REVDAT 3 07-FEB-24 8AUE 1 REMARK REVDAT 2 08-MAR-23 8AUE 1 JRNL REVDAT 1 01-MAR-23 8AUE 0 JRNL AUTH W.B.BREUKELAAR,N.POLIDORI,A.SINGH,B.DANIEL,S.M.GLUECK, JRNL AUTH 2 K.GRUBER,W.KROUTIL JRNL TITL MECHANISTIC INSIGHTS INTO THE ENE-REDUCTASE-CATALYZED JRNL TITL 2 PROMISCUOUS REDUCTION OF OXIMES TO AMINES. JRNL REF ACS CATALYSIS V. 13 2610 2023 JRNL REFN ESSN 2155-5435 JRNL PMID 36846821 JRNL DOI 10.1021/ACSCATAL.2C06137 REMARK 2 REMARK 2 RESOLUTION. 1.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.48 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.040 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 68067 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1157 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.4800 - 3.6300 0.94 8202 142 0.1468 0.1573 REMARK 3 2 3.6300 - 2.8800 0.96 8223 142 0.1643 0.2131 REMARK 3 3 2.8800 - 2.5200 0.99 8447 146 0.1757 0.2057 REMARK 3 4 2.5200 - 2.2900 0.99 8421 146 0.1784 0.2494 REMARK 3 5 2.2900 - 2.1200 0.99 8413 145 0.1757 0.2255 REMARK 3 6 2.1200 - 2.0000 1.00 8470 146 0.1834 0.2214 REMARK 3 7 2.0000 - 1.9000 1.00 8527 148 0.2136 0.2477 REMARK 3 8 1.9000 - 1.8200 0.96 8207 142 0.2526 0.2700 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.282 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.23 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 6092 REMARK 3 ANGLE : 0.819 8275 REMARK 3 CHIRALITY : 0.053 889 REMARK 3 PLANARITY : 0.005 1085 REMARK 3 DIHEDRAL : 14.515 2245 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8AUE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1292123857. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-APR-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.965459 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 123419 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.820 REMARK 200 RESOLUTION RANGE LOW (A) : 46.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.4 REMARK 200 DATA REDUNDANCY : 1.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.2500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.89 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3HGS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM AMINO ACID MIX (0.02M DL REMARK 280 -GLUTAMIC ACID MONOHYDRATE; 0.02M DL-ALANINE; 0.02M GLYCINE; REMARK 280 0.02M DL-LYSINE MONOHYDROCHLORIDE; 0.02M DL-SERINE), 20% V/V REMARK 280 ETHYLENE GLYCOL; 10 % W/V PEG 8000, 100 MM TRIS (BASE), BICINE REMARK 280 PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 44.51300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 ALA A 5 REMARK 465 GLN A 6 REMARK 465 ASP A 7 REMARK 465 GLY A 8 REMARK 465 ASN A 9 REMARK 465 TYR A 287 REMARK 465 GLY A 288 REMARK 465 GLN A 289 REMARK 465 THR A 290 REMARK 465 GLU A 291 REMARK 465 ALA A 292 REMARK 465 GLY A 293 REMARK 465 ARG A 294 REMARK 465 LEU A 295 REMARK 465 GLY A 386 REMARK 465 ASN A 387 REMARK 465 GLY A 388 REMARK 465 SER A 389 REMARK 465 ASN A 390 REMARK 465 GLY A 391 REMARK 465 PRO A 392 REMARK 465 LEU A 393 REMARK 465 SER A 394 REMARK 465 ARG A 395 REMARK 465 LEU A 396 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 HIS B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 ALA B 5 REMARK 465 GLN B 6 REMARK 465 ASP B 7 REMARK 465 GLY B 8 REMARK 465 TYR B 287 REMARK 465 GLY B 288 REMARK 465 GLN B 289 REMARK 465 THR B 290 REMARK 465 GLU B 291 REMARK 465 ALA B 292 REMARK 465 GLY B 293 REMARK 465 ARG B 294 REMARK 465 LEU B 295 REMARK 465 GLY B 296 REMARK 465 GLY B 386 REMARK 465 ASN B 387 REMARK 465 GLY B 388 REMARK 465 SER B 389 REMARK 465 ASN B 390 REMARK 465 GLY B 391 REMARK 465 PRO B 392 REMARK 465 LEU B 393 REMARK 465 SER B 394 REMARK 465 ARG B 395 REMARK 465 LEU B 396 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 116 O HOH A 501 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 63 153.58 -45.93 REMARK 500 ALA A 121 19.36 58.97 REMARK 500 ASP A 205 -159.69 -98.83 REMARK 500 ASP A 205 -159.79 -98.83 REMARK 500 ALA A 247 69.10 -109.90 REMARK 500 ASP A 350 45.33 -97.24 REMARK 500 VAL A 375 -54.62 -126.00 REMARK 500 TYR A 378 -59.75 -132.11 REMARK 500 GLU B 63 151.33 -45.60 REMARK 500 ILE B 80 33.39 -140.89 REMARK 500 ASN B 135 3.88 -67.53 REMARK 500 ASP B 205 -163.64 -104.24 REMARK 500 ASP B 205 -163.89 -104.24 REMARK 500 ALA B 247 74.27 -106.12 REMARK 500 ASP B 350 44.66 -99.02 REMARK 500 VAL B 375 -52.20 -122.67 REMARK 500 TYR B 378 -61.68 -131.43 REMARK 500 REMARK 500 REMARK: NULL DBREF 8AUE A 1 396 UNP Q9FEW9 OPR3_SOLLC 1 396 DBREF 8AUE B 1 396 UNP Q9FEW9 OPR3_SOLLC 1 396 SEQADV 8AUE HIS A -5 UNP Q9FEW9 EXPRESSION TAG SEQADV 8AUE HIS A -4 UNP Q9FEW9 EXPRESSION TAG SEQADV 8AUE HIS A -3 UNP Q9FEW9 EXPRESSION TAG SEQADV 8AUE HIS A -2 UNP Q9FEW9 EXPRESSION TAG SEQADV 8AUE HIS A -1 UNP Q9FEW9 EXPRESSION TAG SEQADV 8AUE HIS A 0 UNP Q9FEW9 EXPRESSION TAG SEQADV 8AUE HIS B -5 UNP Q9FEW9 EXPRESSION TAG SEQADV 8AUE HIS B -4 UNP Q9FEW9 EXPRESSION TAG SEQADV 8AUE HIS B -3 UNP Q9FEW9 EXPRESSION TAG SEQADV 8AUE HIS B -2 UNP Q9FEW9 EXPRESSION TAG SEQADV 8AUE HIS B -1 UNP Q9FEW9 EXPRESSION TAG SEQADV 8AUE HIS B 0 UNP Q9FEW9 EXPRESSION TAG SEQRES 1 A 402 HIS HIS HIS HIS HIS HIS MET ALA SER SER ALA GLN ASP SEQRES 2 A 402 GLY ASN ASN PRO LEU PHE SER PRO TYR LYS MET GLY LYS SEQRES 3 A 402 PHE ASN LEU SER HIS ARG VAL VAL LEU ALA PRO MET THR SEQRES 4 A 402 ARG CYS ARG ALA LEU ASN ASN ILE PRO GLN ALA ALA LEU SEQRES 5 A 402 GLY GLU TYR TYR GLU GLN ARG ALA THR ALA GLY GLY PHE SEQRES 6 A 402 LEU ILE THR GLU GLY THR MET ILE SER PRO THR SER ALA SEQRES 7 A 402 GLY PHE PRO HIS VAL PRO GLY ILE PHE THR LYS GLU GLN SEQRES 8 A 402 VAL ARG GLU TRP LYS LYS ILE VAL ASP VAL VAL HIS ALA SEQRES 9 A 402 LYS GLY ALA VAL ILE PHE CYS GLN LEU TRP HIS VAL GLY SEQRES 10 A 402 ARG ALA SER HIS GLU VAL TYR GLN PRO ALA GLY ALA ALA SEQRES 11 A 402 PRO ILE SER SER THR GLU LYS PRO ILE SER ASN ARG TRP SEQRES 12 A 402 ARG ILE LEU MET PRO ASP GLY THR HIS GLY ILE TYR PRO SEQRES 13 A 402 LYS PRO ARG ALA ILE GLY THR TYR GLU ILE SER GLN VAL SEQRES 14 A 402 VAL GLU ASP TYR ARG ARG SER ALA LEU ASN ALA ILE GLU SEQRES 15 A 402 ALA GLY PHE ASP GLY ILE GLU ILE HIS GLY ALA HIS GLY SEQRES 16 A 402 TYR LEU ILE ASP GLN PHE LEU LYS ASP GLY ILE ASN ASP SEQRES 17 A 402 ARG THR ASP GLU TYR GLY GLY SER LEU ALA ASN ARG CYS SEQRES 18 A 402 LYS PHE ILE THR GLN VAL VAL GLN ALA VAL VAL SER ALA SEQRES 19 A 402 ILE GLY ALA ASP ARG VAL GLY VAL ARG VAL SER PRO ALA SEQRES 20 A 402 ILE ASP HIS LEU ASP ALA MET ASP SER ASN PRO LEU SER SEQRES 21 A 402 LEU GLY LEU ALA VAL VAL GLU ARG LEU ASN LYS ILE GLN SEQRES 22 A 402 LEU HIS SER GLY SER LYS LEU ALA TYR LEU HIS VAL THR SEQRES 23 A 402 GLN PRO ARG TYR VAL ALA TYR GLY GLN THR GLU ALA GLY SEQRES 24 A 402 ARG LEU GLY SER GLU GLU GLU GLU ALA ARG LEU MET ARG SEQRES 25 A 402 THR LEU ARG ASN ALA TYR GLN GLY THR PHE ILE CYS SER SEQRES 26 A 402 GLY GLY TYR THR ARG GLU LEU GLY ILE GLU ALA VAL ALA SEQRES 27 A 402 GLN GLY ASP ALA ASP LEU VAL SER TYR GLY ARG LEU PHE SEQRES 28 A 402 ILE SER ASN PRO ASP LEU VAL MET ARG ILE LYS LEU ASN SEQRES 29 A 402 ALA PRO LEU ASN LYS TYR ASN ARG LYS THR PHE TYR THR SEQRES 30 A 402 GLN ASP PRO VAL VAL GLY TYR THR ASP TYR PRO PHE LEU SEQRES 31 A 402 GLN GLY ASN GLY SER ASN GLY PRO LEU SER ARG LEU SEQRES 1 B 402 HIS HIS HIS HIS HIS HIS MET ALA SER SER ALA GLN ASP SEQRES 2 B 402 GLY ASN ASN PRO LEU PHE SER PRO TYR LYS MET GLY LYS SEQRES 3 B 402 PHE ASN LEU SER HIS ARG VAL VAL LEU ALA PRO MET THR SEQRES 4 B 402 ARG CYS ARG ALA LEU ASN ASN ILE PRO GLN ALA ALA LEU SEQRES 5 B 402 GLY GLU TYR TYR GLU GLN ARG ALA THR ALA GLY GLY PHE SEQRES 6 B 402 LEU ILE THR GLU GLY THR MET ILE SER PRO THR SER ALA SEQRES 7 B 402 GLY PHE PRO HIS VAL PRO GLY ILE PHE THR LYS GLU GLN SEQRES 8 B 402 VAL ARG GLU TRP LYS LYS ILE VAL ASP VAL VAL HIS ALA SEQRES 9 B 402 LYS GLY ALA VAL ILE PHE CYS GLN LEU TRP HIS VAL GLY SEQRES 10 B 402 ARG ALA SER HIS GLU VAL TYR GLN PRO ALA GLY ALA ALA SEQRES 11 B 402 PRO ILE SER SER THR GLU LYS PRO ILE SER ASN ARG TRP SEQRES 12 B 402 ARG ILE LEU MET PRO ASP GLY THR HIS GLY ILE TYR PRO SEQRES 13 B 402 LYS PRO ARG ALA ILE GLY THR TYR GLU ILE SER GLN VAL SEQRES 14 B 402 VAL GLU ASP TYR ARG ARG SER ALA LEU ASN ALA ILE GLU SEQRES 15 B 402 ALA GLY PHE ASP GLY ILE GLU ILE HIS GLY ALA HIS GLY SEQRES 16 B 402 TYR LEU ILE ASP GLN PHE LEU LYS ASP GLY ILE ASN ASP SEQRES 17 B 402 ARG THR ASP GLU TYR GLY GLY SER LEU ALA ASN ARG CYS SEQRES 18 B 402 LYS PHE ILE THR GLN VAL VAL GLN ALA VAL VAL SER ALA SEQRES 19 B 402 ILE GLY ALA ASP ARG VAL GLY VAL ARG VAL SER PRO ALA SEQRES 20 B 402 ILE ASP HIS LEU ASP ALA MET ASP SER ASN PRO LEU SER SEQRES 21 B 402 LEU GLY LEU ALA VAL VAL GLU ARG LEU ASN LYS ILE GLN SEQRES 22 B 402 LEU HIS SER GLY SER LYS LEU ALA TYR LEU HIS VAL THR SEQRES 23 B 402 GLN PRO ARG TYR VAL ALA TYR GLY GLN THR GLU ALA GLY SEQRES 24 B 402 ARG LEU GLY SER GLU GLU GLU GLU ALA ARG LEU MET ARG SEQRES 25 B 402 THR LEU ARG ASN ALA TYR GLN GLY THR PHE ILE CYS SER SEQRES 26 B 402 GLY GLY TYR THR ARG GLU LEU GLY ILE GLU ALA VAL ALA SEQRES 27 B 402 GLN GLY ASP ALA ASP LEU VAL SER TYR GLY ARG LEU PHE SEQRES 28 B 402 ILE SER ASN PRO ASP LEU VAL MET ARG ILE LYS LEU ASN SEQRES 29 B 402 ALA PRO LEU ASN LYS TYR ASN ARG LYS THR PHE TYR THR SEQRES 30 B 402 GLN ASP PRO VAL VAL GLY TYR THR ASP TYR PRO PHE LEU SEQRES 31 B 402 GLN GLY ASN GLY SER ASN GLY PRO LEU SER ARG LEU HET FMN A 401 31 HET O8R A 402 13 HET PEG A 403 7 HET GLY A 404 5 HET EDO A 405 4 HET EDO A 406 4 HET FMN B 401 31 HET O8R B 402 13 HET EDO B 403 4 HET GLY B 404 5 HET EDO B 405 4 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM O8R 2-METHOXYETHYL (2~{Z})-2-HYDROXYIMINO-3-OXIDANYLIDENE- HETNAM 2 O8R BUTANOATE HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM GLY GLYCINE HETNAM EDO 1,2-ETHANEDIOL HETSYN FMN RIBOFLAVIN MONOPHOSPHATE HETSYN O8R 2-METHOXYETHYL (Z)-2-(HYDROXYIMINO)-3-OXOBUTANOATE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 FMN 2(C17 H21 N4 O9 P) FORMUL 4 O8R 2(C7 H11 N O5) FORMUL 5 PEG C4 H10 O3 FORMUL 6 GLY 2(C2 H5 N O2) FORMUL 7 EDO 4(C2 H6 O2) FORMUL 14 HOH *465(H2 O) HELIX 1 AA1 ASN A 10 SER A 14 5 5 HELIX 2 AA2 ALA A 37 ILE A 41 5 5 HELIX 3 AA3 GLN A 43 ALA A 54 1 12 HELIX 4 AA4 THR A 82 LYS A 99 1 18 HELIX 5 AA5 HIS A 115 ALA A 123 5 9 HELIX 6 AA6 GLY A 156 ALA A 177 1 22 HELIX 7 AA7 TYR A 190 LYS A 197 1 8 HELIX 8 AA8 SER A 210 CYS A 215 1 6 HELIX 9 AA9 CYS A 215 GLY A 230 1 16 HELIX 10 AB1 ASN A 251 GLY A 271 1 21 HELIX 11 AB2 SER A 297 TYR A 312 1 16 HELIX 12 AB3 THR A 323 GLN A 333 1 11 HELIX 13 AB4 GLY A 342 ASN A 348 1 7 HELIX 14 AB5 ASP A 350 ASN A 358 1 9 HELIX 15 AB6 ASN A 365 PHE A 369 5 5 HELIX 16 AB7 ASN B 10 SER B 14 5 5 HELIX 17 AB8 ALA B 37 ILE B 41 5 5 HELIX 18 AB9 GLN B 43 ALA B 54 1 12 HELIX 19 AC1 THR B 82 LYS B 99 1 18 HELIX 20 AC2 HIS B 115 ALA B 123 5 9 HELIX 21 AC3 GLY B 156 GLY B 178 1 23 HELIX 22 AC4 TYR B 190 LYS B 197 1 8 HELIX 23 AC5 SER B 210 CYS B 215 1 6 HELIX 24 AC6 CYS B 215 GLY B 230 1 16 HELIX 25 AC7 ASN B 251 GLY B 271 1 21 HELIX 26 AC8 GLU B 298 TYR B 312 1 15 HELIX 27 AC9 THR B 323 GLN B 333 1 11 HELIX 28 AD1 GLY B 342 ASN B 348 1 7 HELIX 29 AD2 ASP B 350 ASN B 358 1 9 HELIX 30 AD3 ASN B 365 PHE B 369 5 5 SHEET 1 AA1 2 TYR A 16 MET A 18 0 SHEET 2 AA1 2 PHE A 21 LEU A 23 -1 O LEU A 23 N TYR A 16 SHEET 1 AA2 9 VAL A 27 LEU A 29 0 SHEET 2 AA2 9 PHE A 59 MET A 66 1 O PHE A 59 N LEU A 29 SHEET 3 AA2 9 VAL A 102 TRP A 108 1 O VAL A 102 N LEU A 60 SHEET 4 AA2 9 GLY A 181 GLY A 186 1 O GLU A 183 N LEU A 107 SHEET 5 AA2 9 VAL A 234 VAL A 238 1 O GLY A 235 N ILE A 184 SHEET 6 AA2 9 TYR A 276 THR A 280 1 O HIS A 278 N VAL A 236 SHEET 7 AA2 9 PHE A 316 SER A 319 1 O ILE A 317 N LEU A 277 SHEET 8 AA2 9 LEU A 338 TYR A 341 1 O SER A 340 N CYS A 318 SHEET 9 AA2 9 VAL A 27 LEU A 29 1 N VAL A 28 O VAL A 339 SHEET 1 AA3 2 ILE A 126 SER A 127 0 SHEET 2 AA3 2 ARG A 153 ALA A 154 1 O ARG A 153 N SER A 127 SHEET 1 AA4 2 ARG A 138 LEU A 140 0 SHEET 2 AA4 2 HIS A 146 ILE A 148 -1 O GLY A 147 N ILE A 139 SHEET 1 AA5 2 TYR B 16 MET B 18 0 SHEET 2 AA5 2 PHE B 21 LEU B 23 -1 O LEU B 23 N TYR B 16 SHEET 1 AA6 9 VAL B 27 LEU B 29 0 SHEET 2 AA6 9 PHE B 59 MET B 66 1 O PHE B 59 N LEU B 29 SHEET 3 AA6 9 VAL B 102 TRP B 108 1 O VAL B 102 N LEU B 60 SHEET 4 AA6 9 GLY B 181 HIS B 185 1 O GLU B 183 N LEU B 107 SHEET 5 AA6 9 VAL B 234 VAL B 238 1 O GLY B 235 N ILE B 182 SHEET 6 AA6 9 TYR B 276 THR B 280 1 O HIS B 278 N VAL B 236 SHEET 7 AA6 9 PHE B 316 SER B 319 1 O ILE B 317 N LEU B 277 SHEET 8 AA6 9 LEU B 338 TYR B 341 1 O SER B 340 N CYS B 318 SHEET 9 AA6 9 VAL B 27 LEU B 29 1 N VAL B 28 O TYR B 341 SHEET 1 AA7 2 ILE B 126 SER B 127 0 SHEET 2 AA7 2 ARG B 153 ALA B 154 1 O ARG B 153 N SER B 127 SHEET 1 AA8 2 ARG B 138 LEU B 140 0 SHEET 2 AA8 2 HIS B 146 ILE B 148 -1 O GLY B 147 N ILE B 139 CRYST1 49.719 89.026 90.074 90.00 100.27 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020113 0.000000 0.003646 0.00000 SCALE2 0.000000 0.011233 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011283 0.00000